SC

Surajit Chanak

Director Director DIN 01409150
DIN 01409150 First appointment Nov 2006 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Nov 2006
Shareholding value Locked Premium profile

About Surajit Chanak

Data last updated:

Surajit Chanak has 19 years in corporate governance. Formerly with 1 company, such as Reviara Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01409150
Primary Designation Director
First Appointment 10 Nov 2006
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Reviara Pharma Private Limited U51397WB2006PTC108068
Director10 Nov 20062006Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Reviara Pharma Private Limited
Premium access

Shareholding and investment profile for Surajit Chanak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surajit Chanak

Surajit Chanak has 19 years in corporate governance. Formerly with 1 company, such as Reviara Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Surajit Chanak is associated with 0 companies as a director.

Surajit Chanak has expertise in General Business.

Surajit Chanak has 19 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available